These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8083806)

  • 81. Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L634,549, in tissue culture and mice.
    Murray PK; Habbersett MC; Meurer RD
    Am J Trop Med Hyg; 1983 Nov; 32(6):1242-50. PubMed ID: 6418014
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Disposition of glycyrrhizin in the perfused liver of rats.
    Ishida S; Sakiya Y; Taira Z
    Biol Pharm Bull; 1994 Jul; 17(7):960-9. PubMed ID: 8000386
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mefloquine effect on disposition of halofantrine in the isolated perfused rat liver.
    Leo KU; Wesche DL; Marino MT; Brewer TG
    J Pharm Pharmacol; 1996 Jul; 48(7):723-8. PubMed ID: 8866337
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hepatobiliary transport of diflunisal conjugates and taurocholate by the perfused rat liver: the effect of chronic exposure of rats to diflunisal.
    Wang M; Dickinson RG
    Life Sci; 1998; 62(8):751-62. PubMed ID: 9489511
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The pharmacokinetics of nifurtimox in chronic renal failure.
    González-Martin G; Thambo S; Paulos C; Vásquez I; Paredes J
    Eur J Clin Pharmacol; 1992; 42(6):671-3. PubMed ID: 1623911
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cyclosporin A and erythromycin: a study of a drug interaction in the in situ perfused rat liver model.
    Hughes CM; Swanton JG; Collier PS
    Biopharm Drug Dispos; 1993 Oct; 14(7):615-25. PubMed ID: 8251616
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of 3,4-dihydroxyphenylpyruvic acid on the metabolism of L-DOPA in isolated perfused rat liver.
    Lindén IB; Niemi S
    Acta Pharmacol Toxicol (Copenh); 1982 Nov; 51(5):434-40. PubMed ID: 7164823
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Trypanosoma cruzi: colony formation and clonal growth in agar.
    Wittner M; Squillante L; Nadler JP; Tanowitz HB
    Exp Parasitol; 1982 Apr; 53(2):255-61. PubMed ID: 7037441
    [No Abstract]   [Full Text] [Related]  

  • 90. The influence of oxygen tension on theophylline clearance in the rat isolated perfused liver.
    Miller R; Oliver IF
    J Pharm Pharmacol; 1986 Mar; 38(3):236-8. PubMed ID: 2871166
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The disposition of pyrimethamine in the rat isolated perfused liver: the effect of suramin.
    Coleman MD; Adjepon-Yamoah K
    J Pharm Pharmacol; 1986 Jul; 38(7):531-2. PubMed ID: 2875156
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Uptake and excretion of the quaternary ammonium compound deptropine methiodide in the isolated perfused rat liver.
    Lavy UI; Hespe W; Meijer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(2):183-92. PubMed ID: 4264684
    [No Abstract]   [Full Text] [Related]  

  • 93. Nifurtimox Inhibits the Progression of Neuroblastoma
    Kong E; Zhu J; Wu W; Ren H; Jiao X; Wang H; Zhang Z
    J Cancer; 2019; 10(10):2194-2204. PubMed ID: 31258723
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Physiological factors influencing insulin clearance by the isolated perfused rat liver.
    McCarroll AM; Buchanan KD
    Diabetologia; 1973 Jun; 9(3):174-7. PubMed ID: 4795008
    [No Abstract]   [Full Text] [Related]  

  • 95. Nifurtimox.
    Am J Health Syst Pharm; 2020 Dec; ():. PubMed ID: 33289026
    [No Abstract]   [Full Text] [Related]  

  • 96. Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox.
    Lang D; Schulz SI; Piel I; Tshitenge DT; Stass H
    Chem Res Toxicol; 2022 Nov; 35(11):2037-2048. PubMed ID: 36209416
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Disposition of nifurtimox and metabolite activity against Trypanosoma cruzi using rat isolated perfused liver.
    González-Martin G; Paulos C; Guevara A; Ponce G
    J Pharm Pharmacol; 1994 May; 46(5):356-9. PubMed ID: 8083806
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The disposition of nifurtimox in the rat isolated perfused liver: effect of dose size.
    González-Martin G; Ponce G; Inostroza V; González M; Paulos C; Guevara A
    J Pharm Pharmacol; 1993 Jan; 45(1):72-4. PubMed ID: 8094453
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
    Booth CL; Brouwer KR; Brouwer KL
    Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Disposition of the antimalarial, mefloquine, in the isolated perfused rat liver.
    Coleman MD; Fleckenstein L; Shipley LA; Heiffer MH
    Biochem Pharmacol; 1988 Jan; 37(2):235-9. PubMed ID: 3257698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.